Arnaud, L., Mathian, A., Devilliers, H., Ruffatti, A., Tektonidou, M., Forastiero, R., . . . Amoura, Z. (2015). Patient-level analysis of five international cohorts further confirms the efficacy of aspirin for the primary prevention of thrombosis in patients with antiphospholipid antibodies. Autoimmunity Reviews, 14(3), 192. https://doi.org/10.1016/j.autrev.2014.10.019
Chicago Style (17th ed.) CitationArnaud, Laurent, et al. "Patient-level Analysis of Five International Cohorts Further Confirms the Efficacy of Aspirin for the Primary Prevention of Thrombosis in Patients with Antiphospholipid Antibodies." Autoimmunity Reviews 14, no. 3 (2015): 192. https://doi.org/10.1016/j.autrev.2014.10.019.
MLA (9th ed.) CitationArnaud, Laurent, et al. "Patient-level Analysis of Five International Cohorts Further Confirms the Efficacy of Aspirin for the Primary Prevention of Thrombosis in Patients with Antiphospholipid Antibodies." Autoimmunity Reviews, vol. 14, no. 3, 2015, p. 192, https://doi.org/10.1016/j.autrev.2014.10.019.